TORONTO, June 24 /CNW/ - Biosign Technologies Inc. (the "Company",
"Biosign") (CNQ: BIOS) announced today that its board of directors has named
Dr. David Silver as chairman, asked Dr. Radu Leca to assume the CEO role, and
welcomed Tony LaVista as director.
Both Silver and Leca are veteran board members, most knowledgeable about
the company's operations and strategy. Silver is a Principal Senior Scientist
at Johns Hopkins University, with extensive experience in the medical device
industry. Leca is Biosign's founding president and creator of its core
LaVista is a Senior Account Manager at Royal Bank of Canada and a founder
of Royal Bank's Knowledge Based Industries (KBI) group. After more than ten
years with the KBI team, LaVista is a recognized expert who truly understands
clients' needs within the high technology sector.
The board appreciated that Biosign has the foundation, the opportunity,
and the capability to deliver profitable growth.
For further information:
For further information: Radu Leca, President & CEO, Biosign
Technologies Inc., Phone: (416) 218-9800 ext. 222, Email: firstname.lastname@example.org